Patient Groups & Pharmaceutical Companies: Effective Partnerships
Stuart PritchardSenior Government Affairs & Policy Manager, GlaxoSmithKline UK
23rd February 2012
Why does industry engage with patient groups?
How does industry engage with patient groups?
GSK’s global patient advocacy principles
GSK Funding & Disclosure
Getting it right: ABPI Code of Practice (Clause 23)
Getting it wrong
Case Studies
Top Related